GSSC – Goldman Sachs ActiveBeta® U.S. Small Cap Equity ETF
Goldman Sachs ActiveBeta® U.S. Small Cap Equity ETF (GSSC) is a Small Blend ETF, issued by Goldman Sachs, $1.1B in assets, 0.20% expense ratio.
Returns as of Oct 23, 2026: 1 week +2.0%, 1 year +22.5%.
Tracks index of small-cap U.S. stocks, using depositary receipts and underlying stocks.
Top holdings
- TXG – 10X Genomics Inc, 0.5%
- CDNA – CareDx Inc, 0.4%
- ENVA – Enova International Inc, 0.4%
- TVTX – Travere Therapeutics Inc, 0.4%
- ALKS – Alkermes Plc, 0.4%
- BSIG – Brightsphere Investment Group Inc, 0.3%
- DAVE – Dave Inc, 0.3%
- ZETA – Zeta Global Holdings Corp, 0.3%
- SNEX – Stonex Group Inc, 0.3%
- ATRC – AtriCure Inc, 0.3%
- ACAD – ACADIA Pharmaceuticals Inc, 0.3%
- ANF – Abercrombie & Fitch Company, 0.3%
- TGTX – TG Therapeutics Inc, 0.3%
- APPN – Appian Corp, 0.3%
- VSAT – ViaSat Inc, 0.3%
- UMBF – UMB Financial Corporation, 0.2%
- BCRX – BioCryst Pharmaceuticals Inc, 0.2%
- JXN – Jackson Financial Inc, 0.2%
- LGND – Ligand Pharmaceuticals Incorporated, 0.2%
- COMP – Compass Inc, 0.2%
- AMRX – Amneal Pharmaceuticals, Inc. Class A Common Stock, 0.2%
- UNFI – United Natural Foods Inc, 0.2%
- PTCT – PTC Therapeutics Inc, 0.2%
- ENS – Enersys, 0.2%
- CMPR – Cimpress NV, 0.2%